Accessibility Menu
 
Valneva Se logo

Valneva Se

(OTC) INRLF

Current Price$3.50
Market Cap$602.31M
Since IPO (2017)+15%
5 Year-71%
1 Year+11%
1 Month-28%

Valneva Se Financials at a Glance

Market Cap

$602.31M

Revenue (TTM)

$174.66M

Net Income (TTM)

$115.19M

EPS (TTM)

$-0.78

P/E Ratio

-4.50

Dividend

$0.00

Beta (Volatility)

0.42 (Low)

Price

$3.50

Volume

170

Open

$3.50

Previous Close

$3.50

Daily Range

$3.50 - $3.50

52-Week Range

$2.82 - $6.28

INRLF News

No articles available.

INRLF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Valneva Se

Industry

Biotechnology

Employees

674

CEO

Thomas Lingelbach, PhD

Headquarters

Saint-Herblain, 44800, FR

INRLF Financials

Key Financial Metrics (TTM)

Gross Margin

39%

Operating Margin

-50%

Net Income Margin

-66%

Return on Equity

-85%

Return on Capital

-29%

Return on Assets

-29%

Earnings Yield

-22.22%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$602.31M

Shares Outstanding

172.09M

Volume

170

Short Interest

0.00%

Avg. Volume

775.117

Financials (TTM)

Gross Profit

$67.52M

Operating Income

$81.63M

EBITDA

$50.47M

Operating Cash Flow

$52.89M

Capital Expenditure

$4.48M

Free Cash Flow

$57.38M

Cash & ST Invst.

$109.65M

Total Debt

$207.25M

Valneva Se Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$47.69M

-9.9%

Gross Profit

$11.62M

-54.8%

Gross Margin

24.36%

N/A

Market Cap

$602.31M

N/A

Market Cap/Employee

$844.76K

N/A

Employees

713

N/A

Net Income

$50.02M

-35.2%

EBITDA

$26.44M

-2.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$97.60M

-103.1%

Accounts Receivable

$27.81M

-21.0%

Inventory

$50.23M

-6.4%

Long Term Debt

$186.60M

-3.3%

Short Term Debt

$20.64M

-11.6%

Return on Assets

-28.88%

N/A

Return on Invested Capital

-28.77%

N/A

Free Cash Flow

$25.59M

-551.6%

Operating Cash Flow

$24.51M

-357.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VBIZFViva Biotech Holdings
$0.34+0.00%
SOLTFNxera Pharma Co., Ltd.
$5.28+0.00%
MDRXVeradigm Inc.
$4.60+2.22%
AVCTFAvacta Group Plc
$0.92+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.55-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.00+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$78.50+0.02%
IBITiShares Bitcoin Trust
$39.28-0.02%

Questions About INRLF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.